Trials / Completed
CompletedNCT01376284
Drug Use Investigation for AVOLVE(BPH)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Male
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to investigate the safety and efficacy of dutasteride capsules 0.5 mg collected from the required number of Japanese subjects with benign prostatic hyperplasia (BPH) in order to identify concerns or problems, if any, about the efficacy and safety of its use at post-marketing clinical settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dutasteride | Collection of safety data |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2013-10-01
- Completion
- 2014-06-01
- First posted
- 2011-06-20
- Last updated
- 2014-07-28
Source: ClinicalTrials.gov record NCT01376284. Inclusion in this directory is not an endorsement.